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ABSTRACT
Objectif: Severe Lassa fever with high mortality among health care providers is usually a human 
to human infection that requires high index of suspicion to diagnose. This case report is to 
describe a peculiar case of Lassa fever among health worker.
Result; A severe form of Lassa fever was diagnosed early in a healthcare provider and patient 
recovered fully.
Conclusion: Fatality can be greatly reduced if early diagnosis as well as prompt specific 
treatment is instituted.
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Fièvre de Lassa: Un rapport de cas
1 1 2 3* Chundusu C M , Isa S E ,Jonathan  B  ,  Datong, P
Rapport de cas
RÉSUMÉ
Contexte de L'Étude: La fièvre de Lassa sévère avec une mortalité élevée chez les fournisseurs
de soins de santé est habituellement un être- humain à l'infection humaine qui nécessite l' indice 
élevé de suspicion pour diagnostiquer.
Objectif: Pour signaler un cas particulier de la fièvre de Lassa Chez travailleurs de la santé.
Résultats: Une forme grave de la fièvre de Lassa a été diagnostiquée tôt et les fournisseurs de 
soins de santé et le patient se sont rétablis complètement.
Conclusion: La fatalité peut être considérablement réduite si le diagnostic précoce ainsi que le 
traitement  spécifique est exécuté.
Mots Clés: E fièvre de Lassa, Jos.
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INTRODUCTION
Lassa virus is primarily transmitted 
by a (multimammate) rat specie Mastomys 
natalensis.  The rat is the reservoir host for 
the virus. Humans get infected when the 
rodent's excreta contaminate food or other 
items within the house, the virus can spread 
secondarily from person to person (1). Most 
infections are mild and subclinical, severe 
multi-systemic disease however occurs in 5-
10% of infections (2) mostly by human to 
human. The illness usually begins insidiously 
with fever, weakness, malaise joint pain or 
lumber pain cough and severe headache. 
P h a r y n g i t i s  o f t e n  e x u d a t i v e  a n d  
conjunctivitis may occur early. In severe 
cases prostration dehydration and facial or 
neck oedema can occur (3). Laboratory 
findings include Serum aminotransferases  
which may be elevated with a pattern similar 
to that seen in alcoholic hepatitis 
( A S T > > A LT )  w i t h  l y m p h o p e n i a ,  
thrombocytopenia and defective platelet 
function though bleeding is limited in 
severity. Serum aminotransferases greater 
than  150iu/l with viraemia usually has 
mortality rate of about 80%. Deafness may 
occur in about 30% of patients.  About 50% 
of affected patients will then recover.(4, 5) In 
Nigeria Lassa fever is said to account for 
most cases of fever associated with deafness 
in adults.(4, 5)
CASE REPORT
This was a 36 year old female nurse 
working at the Accident and Emergency unit 
who presented to the Accident and 
Emergency unit of the Plateau State 
Specialist Hospital in January 2011 with a 
high grade continuous fever, chills and rigors 
of 3 days duration. There was severe 
generalized headache, insomnia and post-
prandial non projectile vomiting. She had no 
neck pain or stiffness. She had earlier on had 
artesunin combine therapy for three days and 
had started ciprofloxacin the previous day 
without improvement. 
She was found to be toxic, febrile with a 
0temperature of 38.0 c, weak and dehydrated. 
She was couscous and alert with no 
neurological deficit or meningeal sign. 
She had a respiratory rate of 28 circles per 
minute and vesicular breath sounds. Pulse 
rate was 92 beats per minute of regular 
moderate volume. Blood pressure was 80/60 
mm of Hg. The apex beat was at the fifth left 
intercostals space mid clavicular line and, 
heart sounds were first and second only. 
Nothing was found on abdominal  
examinations. 
An initial working diagnosis of 
typhoid septicaemia was made initially, 
based on non-responds to antimalarials. She 
was admitted and started on parenteral 
artesunate (E-mal® ),  intravenous 
ceftriazone and 5% dextrose saline were also 
administered.
Laboratory results obtained were 
9PCV 33%, WBC = 8.1 x 10,  [N 57%, L41%, 
M 0.1%, E 0.1%] . Blood and urine culture 
yielded no growth. U/E [Na 120, K 3.8, Cl  
396, Hco  20, urea 2.7 and Cr 78 all in mmol/l]. 
Other results are as seen in the tables.
On the fourth day of admission her 
0
temperature went up to 40.0 c, she became 
restless, dyspnec. She was flaring and had 
puffy face.  Respiratory rate went up to 33 
circles per minute, with posterior basal fine 
crepitations on auscultation. Pulse rate also 
went up to 124 beats per minute, blood 
pressure 100/60 mm of Hg with no added 
sound on auscultation of the precordium.  
There was no sign of bleeding bed side whole 
blood clothing time was greater than 20 
minutes. 
Diagnosis of Lassa fever was made 
based on the above findings and treatment 
was initiated, blood sample was taken to 
closest virology unit (PLASVIREC). 
Confirmation was done in the Netherlands. 
Patient was isolated from other patients and 
all people including medical staff that got in 
contact with the patient were advised to 
report if they had similar symptoms of fever 
and headache. Parenteral ribavirin was 
commenced at a dose of 32mg/kg 6hrly start 
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then 16mm/kg 6hrly for 4days to continue 
with 8mg/kg for another 6days. She made a 
dramatic improvement, temperature came 
down to normal within 72hrs and headache 
stopped. Ceftriazone and E-mal® were 
stopped after 72 hours.  She got the ten day 
course of ribavirin and discharged after 
thirteen days on admission. She had 2 
subsequent follow up visits in which she 
appeared apparently normal, no deafness. 
The viral study was diagnostic of Lassa fever.
DISCUSSIONS
Lassa fever was first documented in a 
nursing staff and has remained a major treat 
to healthcare providers (6). It is again 
unfortunate that most documented outbreaks 
of Lassa fever were obtained following the 
demise of a healthcare provider or a group of 
healthcare providers, a great human and 
economic lost. 
This disease with very high mortality 
of about 80% (4) in severe cases is usually 
associated with high viral load (4,5). A 
situation commonly seen with human to 
human transmission in healthcare providers, 
due possibly to repeated contacts with mild 
cases. We highlighted some factors that 
contributed to the success in the treatment 
outcome of a severe case of Lassa fever. 
 In this report, the nurse would likely have 
had repeated exposure to many mild cases of 
Lassa, a phenomenon seen with many other 
fatal viral infections like severe acute 
respiratory syndrome (SARS), bird-flu virus, 
swine flu virus and more recently  middle 
east respiratory syndrome virus (MERS). 
Clinical diagnosis was suspected on the third 
day of admission when features of severe 
form of the disease started manifesting. 
Symptoms like persistent high grade fever in 
which conventional artesinin combination 
therapy and broad spectrum anti-microbial 
m e d i c a t i o n s  ( t h i r d  g e n e r a t i o n  
cephalosporins) could not control and 
breathlessness suggesting pulmonary 
oedema though viral myocarditis could have 
been a possibility. Prolonged bleeding time 
and high PTTK (Partial Thromboplastin 
Time with Kaolin) test (table 1) highly 
suggested clothing abnormality though there 
were no obvious bleeding (4, 6). Other 
factors that made Lassa fever a more likely 
diagnosis was the season in which the case 
occurred being dry season (7). 
The antibody test to Lassa  virus 
unfortunately does not differentiate active 
disease process from cured state  because an 
individual who recovers from the illness will 
still have the antibody circulating in the body 
for some time (4,5). A local ongoing study in 
symptomless pregnant women in Jos showed 
that about 60-70% had antibodies to Lassa 
virus. National figure documented about 
13% prevalence, in the general population. 
(8) 
Despite developing severe features, 
the patient did survive because ribavirin 
which is currently the only potent drug 
against the Lassa virus was readily available. 
Timely intervention had saved this patient's 
life. Laboratory result of the PTTK (table 1) 
showed a return to the normal value 
following treatment with ribavirin. Similarly 
slight liver enzymes increment was notice 
(table 2) which regressed with treatment. 
Confirmation of the disease was made weeks 
after discharge.
Health care givers are prone to having 
severe form of Lassa fever. The success in 
treatment of Lassa fever depends on early 
diagnoses which for now rely mainly on high 
index of suspicion. (9) Mortality can also be 
greatly reduced when specific treatment with 
ribavirin is started early for the patient who 
could be a healthcare provider whenever 
necessary. 
REFERENCES
1. Buckley SM, Casals J. Path biology of 
Lassa fever. Int Rev Exp Pathol. 
1978;18: 97-136. 
2. McCormick JB, Webb PA, Krebs. A 
prospective study of the epidermiology 
Res. J. of Health Sci. Vol 3(2), April/June 2015                                                       136
Lassa fever: a case report                                                          Chundusu C M, et. al.
and ecology of Lassa fever. J infect dis. 
1987; 55-437
3. Holmes GP, McCormick JB, Trock SC. 
Lassa fever in the United States. 
Investigation of a case and new 
guidelines for management. N Engl J 
Med. Oct 18 1990;323(16):1120-3. 
4. Cummins D, McCormick JB, Bennett 
D. Acute sensorineural deafness in 
Lassa fever. JAMA. Oct 24-31 
1990;264(16):2093-6. 
5. Jay MT, Glaser C, Fulhorst CF. The 
arenaviruses. J Am Vet Med Assoc. 
2005;227:904-15.
6. Frame JD, Baldwin JM, Gocke DJ, 
Troup JM. Lassa fever, a new virus 
disease from West Africa. Clinical 
description and pathological findings. 
A j trop med hyg. 1970; 19:670 
7. Adewuyi G M, Fowotade A, Adewuye 
B T. Lassa fever; Another infectious 
manace. Afr. jornl. of clinical and 
experimental microbiology 2009; 
10(3);244-155
8. Fed Min of Health Nigeria. Weekly 
update on epidemics in Nigeria as at 
th
30  march 2012. April 2012.
9. Isa ES, Shehu NY, Juryul RN, Simji 
SG. Epidemiological and clinical 
description of Lassa fever in Jos, 
Nigeria. High Med Res J 2013; 13:3-7.
Res. J. of Health Sci. Vol 3(2), April/June 2015                                                       137
Lassa fever: a case report                                                          Chundusu C M, et. al.
 
Table 1: Clothing profile of the patient during hospital admission. 
 DAY 3 DAY 6 
 Clothing profile   
PT( prothrimbin time) 
PTTK( Partial Thromboplastin Time with Kaolin) 
1’ 32”           2’ 26” 
52’ 6”           1’ 50” 
    
PTTK was markedly prolonged and returned to normal with commencement of ribavarin.  
 
Table 2:  Liver function tests of the patient during admission 
 DAY 9 DAY 16 
 Liver function test   
Total protein (g/l)                       69         83 
Albumin (g/l)                                    36 33 
Bilirubin total (mmol/l 10.2 10.2 
Bilirubin conjugated (mmol/l)       5.1 5.1 
Alkaline phosphatase (iu/l)             71 44 
Alanine transaminase (iu/l)              19 8 
Aspatate transaminase (iu/l)              13 5 
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